Aussie Device Maker Analytica Pushing Out E-Health Incontinence System
This article was originally published in PharmAsia News
Analytica’s smart phone application features a feedback loop to help women with incontinence and allows physicians to gauge progress for added incentive and compliance value.
You may also be interested in...
Wearable wireless monitoring devices geared toward the fitness market are beginning to attract the attention of the health care industry, which recognizes the technology’s potential to provide an ideal patient monitoring tool. As more of this technology makes its way into the clinical setting, this trend is poised to change the traditional view of what is and is not a medical device.
The Australian immuno-therapeutics developer Prima BioMed has had a change of focus in recent months since buying Paris-based Immutep in late 2014. Prima’s lead product used to be its CVac cancer vaccine, but it has now shifted strategic priority to an LAG-3 immune checkpoint receptor that came with the acquisition.
Phylogica is continuing its strong financial year, with the company’s shares surging after it announced that a pilot study for its cell-penetrating peptides (CPPs) showed these were able to kill drug-resistant breast cancer cells in vivo, when linked with the cancer drug Omomyc.